about
Cytogenetic analyses in 81 patients with brain gliomas: correlation with clinical outcome and morphological data.Imatinib as the first-line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: can we compare real life data to the results from clinical trials?CBFB-MYH11 hypomethylation signature and PBX3 differential methylation revealed by targeted bisulfite sequencing in patients with acute myeloid leukemia.Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders.Primary and recurrent diffuse astrocytomas: genomic profile comparison reveals acquisition of biologically relevant aberrationsEvaluation of 5-year imatinib treatment of 458 patients with CP-CML in routine clinical practice and prognostic impact of different BCR-ABL cutoff levels.Rare congenital chromosomal aberration dic(X;Y)(p22.33;p11.32) in a patient with primary myelofibrosisFluorescence in situ hybridization applied to domestic animal cytogenetics.Molecular cytogenetic analysis of dicentric chromosomes in acute myeloid leukemia.Characterization of a new human plasma cell leukemia cell line UHKT-944.Separation of replication and transcription domains in nucleoli.Mouse models of mantle cell lymphoma, complex changes in gene expression and phenotype of engrafted MCL cells: implications for preclinical research.Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years.Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children.Aberrant expression of the microRNA cluster in 14q32 is associated with del(5q) myelodysplastic syndrome and lenalidomide treatment.An unusual case of high hyperdiploid childhood ALL with cryptic BCR/ABL1 rearrangement.Gain of 1q21 is an unfavorable genetic prognostic factor for multiple myeloma patients treated with high-dose chemotherapy.Characterization of chromosome 11 breakpoints and the areas of deletion and amplification in patients with newly diagnosed acute myeloid leukemia.Recurrent chromosomal breakpoints in patients with myelodysplastic syndromes and complex karyotype versus fragile sites.Rearrangement of 11q13.2 region in two patients with acute myeloid leukemia.From cryptic chromosomal lesions to pathologically relevant genes: integration of SNP-array with gene expression profiling in myelodysplastic syndrome with normal karyotype.Changes associated with lenalidomide treatment in the gene expression profiles of patients with del(5q).Transcription factors Fli1 and EKLF in the differentiation of megakaryocytic and erythroid progenitor in 5q- syndrome and in Diamond-Blackfan anemia.The translocation t(2;11)(p21;q23) without MLL gene rearrangement--a possible marker of good prognosis in myelodysplastic syndrome patients.Change in ploidy status from hyperdiploid to near-tetraploid in multiple myeloma associated with bortezomib/lenalidomide resistance.Genetic and epigenetic characterization of low-grade gliomas reveals frequent methylation of the MLH3 gene.Genome-wide miRNA profiling in myelodysplastic syndrome with del(5q) treated with lenalidomide.A partial nontandem duplication of the MLL gene in four patients with acute myeloid leukemia.Fusion of the additional sex combs like 1 and teashirt zinc finger homeobox 2 genes resulting from ider(20q) aberration in a patient with myelodysplastic syndrome.Involvement of deleted chromosome 5 in complex chromosomal aberrations in newly diagnosed myelodysplastic syndromes (MDS) is correlated with extremely adverse prognosisJumping-like translocation—a rare chromosomal rearrangement in a patient with Burkitt lymphoma/leukemiaComplex karyotype and translocation t(4;14) define patients with high-risk newly diagnosed multiple myeloma: results of CMG2002 trialDeletion of the long arm but not the 5q31 region of chromosome 5 in myeloid malignanciesThrombocytopenia at diagnosis as an important negative prognostic marker in isolated 5q− MDS (IPSS low and intermediate-1)A novel gene LRP5 on 11q13.2 is rearranged in two patients with acute myeloid leukemiaJumping translocations in bone marrow cells of pediatric patients with hematologic malignancies: a rare cytogenetic phenomenonRecurrence of posterior polymorphous corneal dystrophy is caused by the overgrowth of the original diseased host endotheliumUnusually Long Survival of a 67-Year-Old Patient with Near-Tetraploid Acute Myeloid Leukemia M0 without Erythroblastic and Megakaryocytic DysplasiaA novel recurrent chromosomal aberration involving chromosome 7 in childhood myelodysplastic syndrome
P50
Q33287677-2AE11DC5-859B-4295-8FC5-F211EA130C86Q33822710-2A0BF1DA-28D4-4A14-9C28-8F90D6523A52Q34340118-4F20AA52-0756-45DC-A0F8-FEA212785582Q36133050-51B47C39-6359-42FA-9445-3139374BD9B8Q36566055-1789107E-1D69-4E5E-80D1-76900A18BD5DQ36804884-EFD9B33F-2489-41D4-89E1-A02EE9D18487Q37224321-4A86AD68-B563-427B-B64A-AF1BCF430C30Q37656925-1178545C-ADA7-497C-A52D-174116FB49A4Q38798626-913C431B-F45A-4468-B1D4-7E65A3FBA43BQ38918719-32A2559E-D468-4DB5-99CE-72B3425C616FQ38934749-89414ACF-BCAD-4D6B-897B-D145A75F2E3BQ38991388-01BF58E1-8A65-4CFE-848D-0DAE9CA1B2B5Q39608295-D3D8E293-21F3-433A-A44D-5D7C26D0BB0AQ40018345-085B00A0-56FC-4B17-83E7-18495BDF013AQ41058819-05119070-0A8E-468D-A80B-12B5D8C69AC9Q41060122-CE3EF8E3-FDED-44A9-83D4-8502A19054D3Q41978063-14DFAB91-A6B8-4C7E-A7F4-4183DD4CDD8FQ43223973-03E0C4D0-BFBE-40C9-BE7C-B0C6DE17108BQ43410945-9945B78B-ADA7-4D1D-8317-56F65737B20DQ43475554-F2C8FE60-0BD0-426F-9B5C-6A5D70A85DEBQ44973777-CEC582C1-3B4F-4E12-922C-0C8CFC025889Q45405305-58C6033A-82B2-48A9-A3DF-2BD561DBFDA2Q46095097-43E5EB40-43F5-41EB-8BCB-3D9EF0F4768FQ46364652-A25F67C2-C67F-4EE6-B0E9-AFAA33B3AFEBQ47769358-D550D0E4-3B71-43B4-AB8B-88B8A5F57397Q51116437-F4C4767D-856E-4BF3-AD37-E97F5E5EB26CQ52150633-09CC318C-8B76-4072-AF3B-5C1E54646ABBQ53423040-AA37BE3B-4D24-4711-95BA-E93A59536AE5Q54451461-1ABEF5DD-B7FE-4C84-B687-692637DE3E4FQ54778798-1BE67348-7CED-4289-BF9E-828C19A9512FQ58459149-C4A082DE-01BB-4000-8660-8B10B183E3FBQ58459154-C5681581-EB7B-4098-BFE7-8AA6EA7D0785Q58459182-2A54499E-A0C5-4D34-8185-B69B564C499BQ58459187-D62DAF07-DE5E-4A13-A9A4-0978C8772475Q58459207-8BDA28DC-BF5C-46A6-82CC-798DD720AD9AQ58459212-50FEB754-C4D1-4948-8D33-2FD8FBC169A9Q58459227-2580C1D1-17D5-40D8-8D5D-F99DC8527729Q58459234-DFBBCC43-6A56-4CEB-8E58-AEBEC540A2C6Q58459239-63B6B0CA-F03C-48CD-A832-8DE3F6E0CA66Q58459243-660E7663-B851-4642-9D77-83089B4AE9E6
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kyra Michalova
@ast
Kyra Michalova
@en
Kyra Michalova
@es
Kyra Michalova
@nl
Kyra Michalova
@sl
type
label
Kyra Michalova
@ast
Kyra Michalova
@en
Kyra Michalova
@es
Kyra Michalova
@nl
Kyra Michalova
@sl
altLabel
K.Michalova
@en
Kyra Michalova
@en
Michalova K.
@en
Michalová Kyra
@en
prefLabel
Kyra Michalova
@ast
Kyra Michalova
@en
Kyra Michalova
@es
Kyra Michalova
@nl
Kyra Michalova
@sl
P1053
D-8081-2017
P106
P1153
7005370103
P21
P31
P3829
P496
0000-0003-0259-8475
P569
2000-01-01T00:00:00Z